Medicines and pharmacy

Medicines are the most frequently and widely used NHS treatment and account for over 12% of NHS expenditure. A coherent medicines policy aims to control costs, increase patient access and improve value for money. The Department’s policy on medicines and pharmacy covers every step of the journey from the development of medicines to their use by the patient.

Patient Access Scheme: guidance for companies considering a proposal in England

Guidance for companies considering a Patient Access Scheme (PAS) proposal in England, has been published. Following a review of the 2009 Pharmaceutical Price Regulation Scheme provisions on PAS in 2011, … Read more → – Patient Access Scheme: guidance for companies considering a proposal in England

Importance of finger prick tests in managing type 1 diabetes highlighted

Healthcare professionals are being reminded of the importance of finger prick glucose testing for people living with type 1 diabetes. The following points are being highlighted: the requirements placed upon … Read more → – Importance of finger prick tests in managing type 1 diabetes highlighted

Latest topics referred to NICE: December 2012

Department of Health ministers agreed to refer the following topics to the National Institute for Health and Clinical Excellence (NICE) in December, to begin the process of developing guidance for … Read more → – Latest topics referred to NICE: December 2012

Statutory scheme

Companies that do not belong to a voluntary scheme are subject to a statutory arrangement known as the Health Service Branded Medicines (Control of Prices and Supply of Information) (No. … Read more → – Statutory scheme

Electronic prescription service directions 2012 amendment 2

These directions, which come into force on 1 February 2013, enable the 21 primary care trusts (PCTs) listed in the schedule to authorise their primary medical services contractors or any … Read more → – Electronic prescription service directions 2012 amendment 2

PPRS Dispute Resolution Panel on the matter brought before it by Sanofi Pasteur MSD Limited published

The decision dated 3 January 2013 of the Pharmaceutical Price Regulation Scheme Dispute Resolution Panel on the matter brought before it by Sanofi Pasteur MSD Limited is published. This decision … Read more → – PPRS Dispute Resolution Panel on the matter brought before it by Sanofi Pasteur MSD Limited published

Guidance updated on trading of medicines for human use

Updated guidance setting out the key legal and ethical obligations that manufacturers, wholesalers, NHS Trusts, registered pharmacies and dispensing doctors have in the supply and trading of medicines, has been … Read more → – Guidance updated on trading of medicines for human use